Also see: Electronic Arts: Analysts' New Ratings
Editor's Note: Green and red arrows refer to intraday stock price movement.
NEW YORK (
) -- STOCK COMMENTS / EPS CHANGES
price target cut at Barclays to $55 from $60 on fears of weak Humira sales, Barclays said. Maintain Overweight rating.
estimates, target upped at Jefferies. ARG estimates were boosted through 2012, Jefferies said. Company can deliver above-average growth and generates healthy free cash flow. Buy rating and new $70 price target.
Bank of America
estimates cut at Oppenheimer through 2012. Company is seeing weaker trading results and higher costs. Perform rating.
estimates, target raised at Jefferies. Shares of BBT now seen reaching $31, according to Jefferies. Estimates also increased, given improving credit trends. Hold rating.
price target higher at Barclays to $24 from $22 on steady markets and stabilizing outlook, Barclays said. Maintain Equal Weight rating.
estimates, target boosted at UBS. Shares of ETN now seen reaching $106. Estimates also upped, to match the company's new guidance. Neutral rating.
added to Conviction Buy List at Goldman. $165 price target. Company is the low-cost provider and earnings visibility is improving.
price target raised at Credit Suisse to $23 from $22 on improving Power data points, Credit Suisse said. Maintain Outperform rating.
numbers upped at Morgan Stanley through 2012, Morgan Stanley said. Company is carrying a lot of momentum into the new year. Overweight rating and new $23 price target.
numbers raised at Brean Murray. Shares of HPQ now seen reaching $60. Estimates also increased, given higher sales growth potential. Buy rating.
numbers boosted at Goldman. Shares of ISRG now seen reaching $270, according to Goldman Sachs. Estimates also upped, given higher sales and a lower share count. Sell rating.
estimates, target raised at Citigroup. Shares of MET now seen reaching $54, according to Citigroup. Estimates also increased, given a higher expected ROE. Buy rating.
Merck & Co
price target lowered at Barclays to $41 from $43. Products coming out in 2011 and 2012 appear small in revenue upside, Barclays said. Maintain Overweight rating.
estimates lowered at Credit Suisse. NAVG 2010 and 2011 EPS estimates reduced to $2.52 and $3.50, respectively. Reducing estimates for reinstatement premiums, Credit Suisse said. Maintain Neutral rating and $49 price target.
price target boosted at Barclays to $39 from $36. Expecting strong 4Q10 results due to healthy WiFi trends and solid holiday retail environment, Barclays said. Maintain Overweight rating.
numbers increased at Citigroup. PNC estimates were raised through 2012, Citigroup said. Company has a strong capital position and credit trends are improving. Hold rating and new $70 price target.
numbers lowered at Citigroup. Shares of PVH now seen reaching $82, according to Citigroup. Estimates also cut, given gross margin pressures. Buy rating.
estimates, target boosted at Citigroup.Shares of SLB now seen reaching $110, Citigroup said. Estimates also upped, as the company is seeing better North American results. Buy rating.
estimates, target increased at Jefferies. STI estimates were raised through 2013, Jefferies said. Company is seeing better credit and sales trends. Hold rating and new $32 price target.
estimates, target reduced at Citigroup. Shares of SWY now seen reaching $18, according to Citigroup. Estimates also cut, given continued price competition. Sell rating.
estimates lowered at Morgan Stanley. T estimates were reduced through 2012, Morgan Stanley said. Company is facing increased wireless competition from VZ. Overweight rating and $32 price target.
numbers upped at Goldman. WPI estimates were boosted through 2013, Goldman Sachs said. Company has solid earnings visibility. Neutral rating and new $55 price target.
price target raised at Credit Suisse to $64 from $60. Positive commentary at investor meeting and increased guidance, Credit Suisse said. Maintain Outperform rating.
This article was written by a staff member of TheStreet.